These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: NeXstar Pharmaceuticals lauches DaunoXome.
    Journal: J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):52. PubMed ID: 11363700.
    Abstract:
    NeXstar Pharmaceuticals has begun marketing DaunoXome (daunorubicin citrate liposome injection), which maximizes the selectivity of daunorubicin for solid tumors. Phase III trials showed the drug to have efficacy comparable to a three-drug regimen of adriamycin, bleomycin, and vincristine (ABV). There was no evidence of cardiotoxicity except at levels greater than six times higher than would normally be tolerated by the patient.
    [Abstract] [Full Text] [Related] [New Search]